产品
编 号：F656542
分子式：C35H33F4NO5
分子量：623.63
分子式：C35H33F4NO5
分子量：623.63
产品类型
规格
价格
是否有货
1mg
询价
询价
5mg
询价
询价
10mg
询价
询价
25mg
询价
询价
50mg
询价
询价
结构图
CAS No: 1027642-43-8
产品详情
生物活性：
BAY 60-2770 is a potent, selective, and orally active soluble guanylyl cyclase (sGC) activator. BAY 60-2770 increases the activity of sGC in a nitric oxide-independent manner. BAY 60-2770 shows antifibrotic effect.
体内研究：
BAY 60-2770 (0.1-0.3 mg/Kg; p.o.) attenuates liver fibrosis in two rat models.BAY 60-2770 (1 mg/kg; p.o.; daily from the 10th to the 12th week) results in amelioration of bladder dysfunction in high-fat obese mice.Animal Model:Obese mice
Dosage:1 mg/kg
Administration:p.o.; daily from the 10th to the 12th week
Result:Ameliorates detrusor dysfunction in obese mice.
BAY 60-2770 is a potent, selective, and orally active soluble guanylyl cyclase (sGC) activator. BAY 60-2770 increases the activity of sGC in a nitric oxide-independent manner. BAY 60-2770 shows antifibrotic effect.
体内研究：
BAY 60-2770 (0.1-0.3 mg/Kg; p.o.) attenuates liver fibrosis in two rat models.BAY 60-2770 (1 mg/kg; p.o.; daily from the 10th to the 12th week) results in amelioration of bladder dysfunction in high-fat obese mice.Animal Model:Obese mice
Dosage:1 mg/kg
Administration:p.o.; daily from the 10th to the 12th week
Result:Ameliorates detrusor dysfunction in obese mice.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备